TNSN97173A1 - Analogues peptidiques de la lh-rh, leurs utilisations et les compositions pharmaceutiques en contenant. - Google Patents

Analogues peptidiques de la lh-rh, leurs utilisations et les compositions pharmaceutiques en contenant.

Info

Publication number
TNSN97173A1
TNSN97173A1 TNTNSN97173A TNSN97173A TNSN97173A1 TN SN97173 A1 TNSN97173 A1 TN SN97173A1 TN TNSN97173 A TNTNSN97173 A TN TNSN97173A TN SN97173 A TNSN97173 A TN SN97173A TN SN97173 A1 TNSN97173 A1 TN SN97173A1
Authority
TN
Tunisia
Prior art keywords
peptide analogs
same
pharmaceutical compositions
compositions containing
spl
Prior art date
Application number
TNTNSN97173A
Other languages
English (en)
Inventor
Remi Delansorne
Jacques Paris
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of TNSN97173A1 publication Critical patent/TNSN97173A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)

Abstract

CETTE INVENTION CONCERNE DES ANALOGUES PEPTIDIQUES DE LA LH-RH AVEC UNE EXCELLENTE AFFINITE POUR LES RECEPTEURS DE LA LH-RH, DE FORMULE : V-W-X-SPL-Y- Pro -Z OU V,W,X,SPL,Y ET Z SONT TELS QUE DEFINIS DANS LA DESCRIPTION. L'INVENTION CONCERNE AUSSI LES UTILISATIONS DESDIS ANALOGUES PEPTIDIQUES ET LES COMPOSITIONS PHARMACEUTIQUES EN CONTENANT.
TNTNSN97173A 1996-11-14 1997-11-12 Analogues peptidiques de la lh-rh, leurs utilisations et les compositions pharmaceutiques en contenant. TNSN97173A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96402441A EP0842946A1 (fr) 1996-11-14 1996-11-14 Analogues de LHRH à conformation forcée, leur utilisation et composés pharmaceutiques

Publications (1)

Publication Number Publication Date
TNSN97173A1 true TNSN97173A1 (fr) 2005-03-15

Family

ID=8225315

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN97173A TNSN97173A1 (fr) 1996-11-14 1997-11-12 Analogues peptidiques de la lh-rh, leurs utilisations et les compositions pharmaceutiques en contenant.

Country Status (28)

Country Link
US (1) US6153587A (fr)
EP (2) EP0842946A1 (fr)
JP (1) JP2001503444A (fr)
KR (1) KR20000068975A (fr)
CN (1) CN1237979A (fr)
AP (1) AP9901529A0 (fr)
AT (1) ATE196914T1 (fr)
AU (1) AU5481798A (fr)
BR (1) BR9713060A (fr)
CA (1) CA2270158A1 (fr)
CO (1) CO4930283A1 (fr)
CZ (1) CZ172899A3 (fr)
DE (1) DE69703308D1 (fr)
EE (1) EE9900174A (fr)
HU (1) HUP0000249A3 (fr)
ID (1) ID21990A (fr)
IL (1) IL129821A0 (fr)
JO (1) JO1999B1 (fr)
MA (1) MA26447A1 (fr)
NO (1) NO992298L (fr)
NZ (1) NZ335454A (fr)
OA (1) OA11045A (fr)
PE (1) PE16899A1 (fr)
PL (1) PL333358A1 (fr)
TN (1) TNSN97173A1 (fr)
TR (1) TR199901054T2 (fr)
WO (1) WO1998021229A1 (fr)
ZA (1) ZA9710254B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor
EP0842946A1 (fr) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Analogues de LHRH à conformation forcée, leur utilisation et composés pharmaceutiques
EP0882736A1 (fr) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. Analogues peptidiques du LH-RH, leurs utilisations et compositions pharmaceutiques les contenant
EP0998940A1 (fr) * 1998-09-30 2000-05-10 Laboratoire Theramex Compositions pharmaceutiques à base de alpha-cyclodextrine pour administration orale d'analogues de LH-RH
KR100679878B1 (ko) * 1999-04-26 2007-02-07 아지노모토 가부시키가이샤 멜라노사이트-자극 호르몬 억제제
WO2008033924A2 (fr) * 2006-09-12 2008-03-20 Board Of Regents Of The University Of Nebraska Méthodes et compositions pour l'administration ciblée d'agents thérapeutiques
EP4225771A1 (fr) * 2020-10-08 2023-08-16 Dignify Therapeutics, LLC Compositions pour induire la miction et la défécation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377515A (en) * 1979-10-01 1983-03-22 Merck & Co., Inc. Long lasting agonists and antagonists of LH-RH
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
EP0842946A1 (fr) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Analogues de LHRH à conformation forcée, leur utilisation et composés pharmaceutiques

Also Published As

Publication number Publication date
CO4930283A1 (es) 2000-06-27
NO992298L (no) 1999-07-08
PL333358A1 (en) 1999-12-06
AP9901529A0 (en) 1999-06-30
NO992298D0 (no) 1999-05-12
KR20000068975A (ko) 2000-11-25
ZA9710254B (en) 1998-05-28
EP0937101B1 (fr) 2000-10-11
PE16899A1 (es) 1999-02-19
IL129821A0 (en) 2000-02-29
AU5481798A (en) 1998-06-03
TR199901054T2 (xx) 1999-07-21
OA11045A (en) 2003-03-07
CA2270158A1 (fr) 1998-05-22
NZ335454A (en) 2000-10-27
EP0842946A1 (fr) 1998-05-20
WO1998021229A1 (fr) 1998-05-22
HUP0000249A2 (en) 2000-07-28
JO1999B1 (en) 1999-05-15
EE9900174A (et) 1999-12-15
HUP0000249A3 (en) 2000-11-28
BR9713060A (pt) 2000-04-11
EP0937101A1 (fr) 1999-08-25
JP2001503444A (ja) 2001-03-13
US6153587A (en) 2000-11-28
MA26447A1 (fr) 2004-12-20
ATE196914T1 (de) 2000-10-15
CN1237979A (zh) 1999-12-08
DE69703308D1 (de) 2000-11-16
ID21990A (id) 1999-08-19
CZ172899A3 (cs) 1999-08-11

Similar Documents

Publication Publication Date Title
TNSN98075A1 (fr) Analogues peptidiques de la lh-rh, leur utilisation et les compositions pharmaceutiques les contenant.
MY113806A (en) Antiparasitic marcfortines and paraherquamides
ES2139360T3 (es) Preparaciones de suspensiones de peptidos o proteinas.
TNSN97015A1 (fr) Nouveaux derives de 19-nor-pregnene.
TNSN98227A1 (fr) Association pharmaceutique pour le traitement d'un dysfonctionnement sexuel et compositions la contenant.
TNSN00239A1 (fr) DERIVES DE PYRROLO [2,3-d] PYRIMIDINE NOUVEAUX, ET COMPOSITIONS LES CONTENANT
JP2000512339A5 (fr)
TNSN99172A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00191A1 (fr) Composes nouveaux, compositions les contenant et leur utilisation dans le traitement d'une ischemie
TNSN98017A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant.
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
ATE300533T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten
TNSN96165A1 (fr) Nouveaux pesticides.
EP1641423A4 (fr) Antagonistes du recepteur du cgrp de
RU97118224A (ru) Соединения и композиции для доставки активных агентов
TNSN99126A1 (fr) Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99252A1 (fr) Composes nouveaux modulateurs de chimiokine ccr5 et compositions pharmaceutiques les contenant.
BG104247A (en) Resorcinol derivatives
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
TNSN99001A1 (fr) Indoles 2,3-substitues servant d'agents anti-inflammatoires et analgesiques
BE1014502A5 (fr) Compositions pharmaceutiques.
TNSN97173A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et les compositions pharmaceutiques en contenant.
KR100292396B1 (fr)
EA200000198A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов
EP1005324A4 (fr) Compositions diffusant des agents biologiques et leurs procedes de preparation